Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease
Authors:
Open Access
- 1 July 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 74 (7) , 672-687
Abstract
Human cerebrospinal fluid (CSF) contains diverse lipid particles, including lipoproteins that are distinct from their plasma counterparts and containKeywords
This publication has 134 references indexed in Scilit:
- Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shiftBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortexNeurobiology of Disease, 2012
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionAnnals of Neurology, 2010
- CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentMovement Disorders, 2010
- Proposed mechanism for lipoprotein remodelling in the brainBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Flow cytometric analysis of circulating microparticles in plasmaCytometry Part A, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Membrane vesicles as conveyors of immune responsesNature Reviews Immunology, 2009
- Alzheimer's disease beta-amyloid peptides are released in association with exosomesProceedings of the National Academy of Sciences, 2006